Swiss Pharma Giant Roche Buys PathAI for Up to $1.05 Billion
Key Points: Roche agreed to buy the American artificial intelligence company PathAI for a massive $750 million upfront cash payment. The contract includes another $300 million in potential bonus payments if the technology firm hits specific business milestones. PathAI will officially join Roche's large global diagnostics division in the second half of 2026. The two healthcare businesses had worked closely together for 5 straight years...